Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713150 · ClinicalTrials.gov registry record
HEALthy Brain and Child Development Study - COVID-19 Supplement
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 62
- Enrollment target
NCT04713150 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 62 participants.
The verdict
NCT04713150 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic and will work to better support these families and children as they grow.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2023-09-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04713150
The ClinicalTrials.gov registry entry for NCT04713150 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT04713150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04713150 about?
NCT04713150 is a clinical study titled "HEALthy Brain and Child Development Study - COVID-19 Supplement". The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic ...
What is the current status of trial NCT04713150?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2020-10-05. Estimated completion is 2023-09-14.
What interventions are being tested in trial NCT04713150?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT04713150?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.